James Rosinski
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Plant Gene Expression Analysis
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Plant biochemistry and biosynthesis
Papers in
-
- Ubiquitin and proteasome pathways 1
- Glycosylation and Glycoproteins Research 1
- FOXO transcription factor regulation 1
- Protein Degradation and Inhibitors 1
- Gene expression and cancer classification 1
- Oncology 4
- Cancer-related Molecular Pathways 2
- Co-authors
- William R. Atchley (2 shared papers)Holly Hilton (4 shared papers)Ola Myklebost (1 shared paper)Kenneth Kolinsky (1 shared paper)Binh Thanh Vu (1 shared paper)Weiguo Qing (1 shared paper)Christian Tovar (1 shared paper)Lyubomir T. Vassilev (1 shared paper)
- Journals
- Journal of Molecular Evolution (2 papers)The FASEB Journal (2 papers)International Journal of Oncology (1 paper)Cellular and Molecular Life Sciences (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
James Rosinski
11 papers receiving 1.1k citations
James Rosinski's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 439
- Molecular Biology 778
- Cancer Research 126
- Biotechnology 79
- Plant Science 192
Countries citing papers authored by James Rosinski
This map shows the geographic impact of James Rosinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rosinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rosinski more than expected).
Fields of papers citing papers by James Rosinski
This network shows the impact of papers produced by James Rosinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rosinski. The network helps show where James Rosinski may publish in the future.
Co-authors
The 25 scholars most cited alongside James Rosinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 556 |
| 2 | 1998 | 257 | |
| 3 | 2003 | 121 | |
| 4 | 2003 | 73 | |
| 5 | 2007 | 61 | |
| 6 | 1999 | 51 | |
| 7 | 2009 | 18 | |
| 8 | 2012 | 7 | |
| 9 | 1992 | 6 | |
| 10 | 2007 | 3 | |
| 11 | Herceptin-refractory ovarian carcinoma cells differentially express genes involved in angiogenesis, invasion, and metastasis | 2005 | 1 |
| 12 | 2008 | 1 |
About James Rosinski
James Rosinski is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Biomarkers in Disease Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper), Glycosylation and Glycoproteins Research (1 paper), Galectins and Cancer Biology (1 paper), FOXO transcription factor regulation (1 paper), Protein Degradation and Inhibitors (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Oncology (439 citations), Molecular Biology (778 citations), Cancer Research (126 citations), Biotechnology (79 citations) and Plant Science (192 citations). James Rosinski has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include William R. Atchley, Holly Hilton, Ola Myklebost, Kenneth Kolinsky, Binh Thanh Vu, Weiguo Qing, Christian Tovar, Lyubomir T. Vassilev, Zoran Filipovic and David Heimbrook. Their work appears in journals such as Journal of Molecular Evolution, The FASEB Journal, International Journal of Oncology, Cellular and Molecular Life Sciences and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.